NCT01685398View on ClinicalTrials.gov

Topical Timolol for Superficial Infantile Hemangioma

PHASE3CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

March 31, 2023

Study Completion Date

March 31, 2023

Conditions
Hemangioma
Interventions
DRUG

0.5% timolol maleate eye drop

DRUG

Normal saline

Trial Locations (1)

10700

Faculty of Medicine Siriraj Hospital Mahidol University, Bangkoknoi

All Listed Sponsors
lead

Mahidol University

OTHER

NCT01685398 - Topical Timolol for Superficial Infantile Hemangioma | Biotech Hunter | Biotech Hunter